Short answer · Medically reviewed summary · Last updated: 2026-04-06
Guillain-Barre Syndrome (GBS) is primarily caused by an aberrant autoimmune response where the body's immune system mistakenly attacks its own peripheral nerves, often triggered by a preceding infection. The Mechanism of Attack To understand Guillain-Barre Syndrome, imagine your nerves as electrical wires insulated by a protective coating called myelin. In GBS, the immune system—designed to fight off foreign invaders—becomes confused.
22 people with Guillain-Barre Syndrome have shared their first-person experience on this question at DiseaseMaps.
Guillain-Barre Syndrome (GBS) is primarily caused by an aberrant autoimmune response where the body's immune system mistakenly attacks its own peripheral nerves, often triggered by a preceding infection.
To understand Guillain-Barre Syndrome, imagine your nerves as electrical wires insulated by a protective coating called myelin. In GBS, the immune system—designed to fight off foreign invaders—becomes confused. It identifies these myelin sheaths or the nerve fibers themselves as threats, leading to inflammation and damage. This disruption prevents nerves from sending signals effectively to your muscles, resulting in the characteristic numbness and paralysis associated with Guillain-Barre Syndrome.
While the exact cause remains a subject of ongoing research, we know that two-thirds of patients report a gastrointestinal or respiratory infection in the weeks preceding the onset of Guillain-Barre Syndrome. Common culprits include the bacterium Campylobacter jejuni or viruses like Zika, influenza, or Epstein-Barr. It is vital to distinguish between a "cause" (the autoimmune attack) and a "trigger" (the infection that sets that attack in motion). Genetic factors are currently not considered a primary driver; most cases occur sporadically, meaning there is no clear hereditary pattern or specific gene mutation linked to the development of the disease.
Medical researchers are actively investigating why certain individuals develop Guillain-Barre Syndrome after an infection while the vast majority do not. Current studies are focused on molecular mimicry—a process where the infectious agent shares structural similarities with human nerve tissue, causing the immune system to misfire. Understanding this mechanism is the gold standard for developing preventive strategies and more targeted immunotherapies for those living with Guillain-Barre Syndrome.
Medical Disclaimer: This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.